Skip to main content
. 2017 Oct 12;153(2):203–213. doi: 10.1111/imm.12830

Figure 3.

Figure 3

Wnt7a reduces phagocytic ability of monocyte‐derived macrophages (MDMs). (a) Phagocytic potential of human M‐MDM with or without Wnt1 or Wnt7a treatment was assessed using immune fluorescence (a) of pHrodo® Red Staphylococcus aureus Bioparticles®, white arrows indicate non‐phagocytic cells (n = 3) and by flow cytometry (b) for PE (excitation 585 nm) MFI of experimental group in comparison with control MDMs (n = 3, *P < 0·05 for M‐MDM versus M‐MDM + Wnt7a).